TTVA

BIOLOGICAL2 trials

Sponsors

CanSino Biologics Inc.

Conditions

Tetanus

Phase 1

A Study to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

CompletedNCT06123663

CanSino Biologics Inc.Tetanus

Start: 2023-12-20End: 2024-06-18Updated: 2024-11-29

Phase 3

A Clinical Trial to Evaluate the Safety and Immunogenicity of a Single Dose of Adsorbed Tetanus Vaccine in a Population Aged 18 Years and Over

CompletedNCT06120751

CanSino Biologics Inc.Tetanus

Start: 2024-03-20End: 2024-09-30Updated: 2026-08-05